Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Effectiveness and safety of novel oral anticoagulants as compared with vitamin K antagonists in the treatment of acute symptomatic venous thromboembolism: a systematic review and meta-analysis

Published:2014-03 Issue:3 Volume:12 Page:320-328
ISSN:1538-7933
Container-title:Journal of Thrombosis and Haemostasis
language:en
Short-container-title:J Thromb Haemost

Author:

van der Hulle T.¹,Kooiman J.¹,den Exter P. L.¹,Dekkers O. M.²,Klok F. A.¹,Huisman M. V.¹

Affiliation:

1. Department of Thrombosis and Hemostasis; Leiden University Medical Center; Leiden The Netherlands

2. Departments of Clinical Epidemiology and Endocrinology and Metabolic Diseases; Leiden University Medical Center; Leiden the Netherlands

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jth.12485/fullpdf

Reference31 articles.

1. Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism;Hutten;Cochrane Database Syst Rev,2006

2. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism;Carrier;Ann Intern Med,2010

3. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis;Linkins;Ann Intern Med,2003

4. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy;Douketis;Arch Intern Med,2000

5. New oral anticoagulant drugs in cardiovascular disease;Ahrens;Thromb Haemost,2010

Cited by 451 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Controlling Prescribing through “Preferred Drug” Targets—The Bavarian Experience;International Journal of Environmental Research and Public Health;2024-09-03

2. Tailoring oral anticoagulant treatment in the era of multi-drug therapies for PAH and CTEPH;Blood Reviews;2024-09

3. Clinical and Economic Consequences of a First Major Bleeding Event in Patients Treated with Direct Factor Xa Inhibitors in Spain: A Long-Term Observational Study;Journal of Clinical Medicine;2024-07-21

4. Anticoagulation and compression therapy for proximal acute deep vein thrombosis;Vasa;2024-07-17

5. Outcomes of deep venous thrombosis management and associated factors among patients in tertiary hospitals in Addis Ababa, Ethiopia: a multicenter retrospective cohort study;Thrombosis Journal;2024-07-12